CXCR4 and colorectal carcinoma: The success of this new approach relies again on achieving highly selective targeted drug delivery by exploiting the CXCR4 membrane overexpression of CRC cells as compared to normal tissues but also due to T22-PE24-H6 multivalency since it leads to super selectivity in target cell internalization (Liu et al., 2020).